Document ID: chunk:federal_register_of_legislation:F2024C00212:front:0:p5
Version: federal_register_of_legislation:F2024C00212
Segment Type: other
Provision Reference: 
Character Range: 11203–14103

persistent infection of the laryngeal epithelium with human papillomavirus type 16 or 18 before the clinical onset of malignant neoplasm of the larynx;
(14)      consuming maté:
(a)          on more days than not; and
(b)          for at least 5 years before the clinical onset of malignant neoplasm of the larynx; and
         if consumption of maté has ceased before the clinical onset of malignant neoplasm of the larynx, then that onset occurred within 15 years of cessation;
(15)      inability to consume an average of at least 200 grams per day of any combination of fruits and vegetables, for a period of at least 5 consecutive years within the 20 years before the clinical onset of malignant neoplasm of the larynx;
(16)      having gastro-oesophageal reflux disease for at least the 5 years before the clinical onset of malignant neoplasm of the larynx;
(17)      inhaling or ingesting opium on average at least weekly for at least 10 years before the clinical onset of malignant neoplasm of the larynx;
Note: opium is defined in the Schedule 1 - Dictionary.
(18)      inhaling high concentrations of polycyclic aromatic hydrocarbons, through work involving a specified industry, manufacturing process or agent:
(a)          for a cumulative period of at least 1,500 hours before the clinical onset of malignant neoplasm of the larynx; and
(b)          where the first inhalation of polycyclic aromatic hydrocarbons occurred at least 5 years before the clinical onset of malignant neoplasm of the larynx;
            Note: polycyclic aromatic hydrocarbons and specified industry, manufacturing process or agent are defined in the Schedule 1 – Dictionary.
(19)      using manual welding equipment for welding metal for a cumulative period of at least 10 years before the clinical onset of malignant neoplasm of the larynx;
(20)      inability to obtain appropriate clinical management for malignant neoplasm of the larynx.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factor set out in subsection 9(20) applies only to material contribution to, or aggravation of, malignant neoplasm of the larynx where the person's malignant neoplasm of the larynx was suffered or contracted before or during (but did not arise out of) the person's relevant service.
     11           Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1)          if a factor referred to in section 9 applies in relation to a person; and
(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;
then the factors in that Statement of Principles apply in accordance with the terms of that Statement